These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 18171092

  • 21. Transbilayer complementarity of phospholipids in cholesterol-rich membranes.
    Zhang J, Jing B, Tokutake N, Regen SL.
    Biochemistry; 2005 Mar 08; 44(9):3598-603. PubMed ID: 15736969
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Spectrin-phospholipid interactions. Existence of multiple kinds of binding sites?
    Grzybek M, Chorzalska A, Bok E, Hryniewicz-Jankowska A, Czogalla A, Diakowski W, Sikorski AF.
    Chem Phys Lipids; 2006 Jun 08; 141(1-2):133-41. PubMed ID: 16566912
    [Abstract] [Full Text] [Related]

  • 26. Interaction of local anaesthetics with lipid membranes under inflammatory acidic conditions.
    Tsuchiya H, Mizogami M, Ueno T, Takakura K.
    Inflammopharmacology; 2007 Aug 08; 15(4):164-70. PubMed ID: 17701019
    [Abstract] [Full Text] [Related]

  • 27. Sterol carrier protein-2-facilitated intermembrane transfer of cholesterol- and phospholipid-derived hydroperoxides.
    Vila A, Levchenko VV, Korytowski W, Girotti AW.
    Biochemistry; 2004 Oct 05; 43(39):12592-605. PubMed ID: 15449949
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The role of the anticancer drug vinorelbine in lipid bilayers using differential scanning calorimetry and molecular modeling.
    Koukoulitsa C, Kyrikou I, Demetzos C, Mavromoustakos T.
    Chem Phys Lipids; 2006 Oct 05; 144(1):85-95. PubMed ID: 16962086
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The influence of fatty acids on model cholesterol/phospholipid membranes.
    Hac-Wydro K, Wydro P.
    Chem Phys Lipids; 2007 Nov 05; 150(1):66-81. PubMed ID: 17651712
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs.
    Niu SL, Mitchell DC, Litman BJ.
    Biochemistry; 2005 Mar 22; 44(11):4458-65. PubMed ID: 15766276
    [Abstract] [Full Text] [Related]

  • 36. Chirality Effect on Cholesterol Modulation of Protein Function.
    Belani JD.
    Adv Exp Med Biol; 2019 Mar 22; 1115():3-19. PubMed ID: 30649753
    [Abstract] [Full Text] [Related]

  • 37. Actin-induced perturbation of PS lipid-cholesterol interaction: A possible mechanism of cytoskeleton-based regulation of membrane organization.
    Garg S, Tang JX, Rühe J, Naumann CA.
    J Struct Biol; 2009 Oct 22; 168(1):11-20. PubMed ID: 19366633
    [Abstract] [Full Text] [Related]

  • 38. Cholesterol displacement from membrane phospholipids by hexadecanol.
    Ratajczak MK, Ko YT, Lange Y, Steck TL, Lee KY.
    Biophys J; 2007 Sep 15; 93(6):2038-47. PubMed ID: 17526582
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.